Bio Elpida, CDMO for Cell Culture Optimisation
Culture conditions and medium type, adaptation to synthetic media

Bio Elpida proposes optimisation studies for cell culture, especially for:
  • The optimisation of medium type,
  • The adaptation to synthetic media,
  • The adaptation to serum free media.

Bio Elpida manufacture specific media and is certified by ANSM (French Medical Regulatory Agency) for the manufacturing of "Annex Therapeutic Product" such as culture media. All operations are performed in the pharmaceutical zone.

Bio Elpida

Founded in 2009, Bio Elpida is a Biotechnology Contract Development and Manufacturing Company specialised in the development and manufacturing of innovative cell therapies.

The expertise of the company covers 3 areas:
In these areas, Bio Elpida offers services that include:
Bio Elpida is the first French laboratory certified by the French Health Authorities (MSNA) as a Pharmaceutical Company and authorised to manufacture Active Pharmaceutical Ingredients for experimental biological pharmaceuticals.
Expertise
Services
R&D and Feasibility
Pharmaceutical Development
Single-Use Approach
Optimisation & Scale up
Analytical Method
Manufacturing and Control
Testing
Aseptic Fill & Finish
Support
Formulation
Regulation IMPD
Drug Analytical Development
Bulk Purification


Facilities
R&D Facilities
Feasibility Facilities
API Facilities
ATMP Facilities

Team


Company

News

Contact
Bio Elpida - 97 allée Alexandre Borodine - Bâtiment 5 Cèdre 1 - 69800 Saint Priest - FRANCE - Phone: +33 (0)4 78 47 02 70 - Mail: infos@bio-elpida.com
© Bio Elpida. All Rights Reserved - Legal information - Web site by: Estium-Concept
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  • Your CDMO for
    Innovative Therapy
    SEARCH
    INNOVATE
    ACHIEVE
  •  
  •  
  •